Remove Article Remove Licensing Remove Public Health Remove World Health
article thumbnail

Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics

Bill of Health

During large transnational public health crises, global demand soars for diagnostics, drugs, and vaccines. At the research and development (R&D) stage, government funders can bind producers to equity goals through targeted contractual provisions, as we explain in a recently-published Nature Biotechnology article.

article thumbnail

Better Health Care Tests, Faster

Healthcare IT Today

The previous articles in this series laid out some of the issues in health care affecting testing , and the value of data. This article looks at some specific problems and solutions. Virax Biolabs uses data from the World Health Organization and others to develop tests quickly.

COVID-19 106
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

Monsanto and Myriad) ( this 2015 article discusses the history and taxonomy of patent pledges, many of which are collected in this online database ). In short, these public statements, if made in a manner that is intended to be taken seriously (e.g., After the pandemic, it is willing to offer paid licenses. Pandemic Pledges.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

A new template for the Certificate of a Pharmaceutical Product will be put into use in line with China’s pharmaceutical export practices and the latest World Health Organization (WHO) guidelines. The application/notification must be submitted via the EUDAMED database (Article 69 IVDR).

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – July and August 2023

SQA

In addition, it contains essential recommendations to avoid complications and protect public health. Aimed at both consumers and professionals of aesthetic clinics, the alert clarifies the precautionary ban on certain products. The addition of Annex 2, which describes the CPCA for N -nitrosamines.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – July/August

SQA

Health Canada is warning consumers about counterfeit BTNX Rapid Response COVID-19 antigen rapid test kits (25-pack boxes) found in Ontario. The counterfeit devices were sold online by a distributor named Healthful Plus without the required license to import, distribute, or sell medical devices in Canada.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

” If the product is prohibited in Brazil, a notice of infraction is drawn up for smuggling of goods (Article 334 A, item II, of the Criminal Code), which is then sent to the Public Prosecutor’s Office for criminal investigation. After this period, the product is characterized as an “abandoned commodity.”

FDA 52